← FDA Drug Approvals (Drugs@FDA)

BRIMONIDINE TARTRATE AND TIMOLOL MALEATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ · Approved 2022-04-04

Drug application

FDA Application #

ANDA091087

Application type

Abbreviated New Drug Application (Generic)

Brand name

BRIMONIDINE TARTRATE AND TIMOLOL MALEATE

Generic name

BRIMONIDINE TARTRATE AND TIMOLOL MALEATE

Active ingredients

BRIMONIDINE TARTRATE; TIMOLOL MALEATE

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

SANDOZ

Manufacturer

Sandoz Inc

First approval

2022-04-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown